CATEGORIES

Scientists Took To Streets For Robust Funds

Thousands of scientists, students, educational NGOs and science enthusiasts across the country came out on the streets on August 9th demanding robust funding for scientific research and policies to encourage a scientific temper among the population.

​“In India Till Now, Bioresearch Is Considered To Be A Bit Costly”

Dr Ashes Ganguly, founder Director of Cryogen Instruments India, one of the leading suppliers of Speciality/Isotopic Gases and Nuclear Medicines in the country, is heading the Indian Analytical Instrument Association (IAIA) as president since 2015 till 2018. In an interaction with BioSpectrum he shares his views as President of IAIA on government’s Make in India scheme and GST etc. Experts of the interview.

“Devise Simple Health Insurance Products To Enhance Coverage”

FICCI HEALTH INSURANCE CONFERENCE 2017

Batavia Joins International Consortium For Polio Eradication

Netherlands based Batavia Biosciences is joining an international consortium to develop and manufacture a safer type of polio vaccine.

Versatility Is Key To Success

Being the President and Chief of Science & Innovation at Metropolis Healthcare Ltd., India’s only multinational chain of pathology centre that provides the largest service menus in India offering more than 4,500 varieties of tests, Dr Nilesh Shah has been an inspirational figure.

Accurate Diagnosis, Efficient Disease Management: Modern Age of Pathology

The world of pathology labs has grown by leaps and bounds in the past decade.

The Policy Is A Game Changer

Recently, JP Nadda, Union Minister for Health and Family Affairs, released the National Health Policy (NHP) 2017. Patting the back of the minister, Prime Minister Narendra Modi described the policy as a ‘futuristic’ document which places the interests of the citizens foremost.

Policy Covers NCD Concerns

The National Health Policy 2017 covers various aspects like care for major non-communicable diseases (NCDs), geriatric healthcare, mental health, palliative care and rehabilitative care services.

The Generic Drug Push Needs Further Clarity

The policy encourages indigenous production of APIs and Key Starting Materials (KSMs) in several ways. However, a more thorough approach is required to once again enable the domestic API industry to become competitive. The Indian government needs to focus on developing the local chemical industry which can then in turn support API manufacturing.

Aims At Providing A Longer Term Stable Policy Environment

To overcome the challenges like Declining CAGR; Non-adherence to quality standards and norms; Growing competition from other countries; Dependence on imports for the key starting materials as also of the APIs; Lack of R&D and discovery of new molecules, and to improve the situation of the pharma industry, India has come up with draft pharma policy 2017.

Amgen Collaborates With Humana To Improve Health Outcomes

US Biotechnology company, Amgen and leading health organization, Humana have teamed up to identify opportunities to improve health outcomes and improve efficiency by unlocking new insights from the real world health care experiences of Humana's 13 million members.

Rich Agricultural Base To Boost State's Biotech Sector

Punjab, one of the prominent agricultural states of the country, is now shifting its gears from just being an agricultural state to biotechnology hub of North India.

Can State Make Biotech Park A Reality?

Governments worldwide have recognised biotech as a new age technology that is anticipated to play a significant role in improving the quality of life, at large.

“The Field Of Healthcare Is Changing Big Time Now”

“The Field Of Healthcare Is Changing Big Time Now”

Over 1500 Exhibitors From 40 Countries Showcase Their Products

Over 1500 Exhibitors From 40 Countries Showcase Their Products

With Proper Government Support India Can Rule Medical Device Sector

With Proper Government Support India Can Rule Medical Device Sector

NB Ventures Invest Into Mobiefit

NB Ventures Invest Into Mobiefit

Cadila Pharma Receives Healthcare Leadership Award

Cadila Pharma Receives Healthcare Leadership Award

Merck To Set Up Research Facility In London

Merck To Set Up Research Facility In London

Clermont Invests Rs 155cr In Indiabulls Pharma

Clermont Invests Rs 155cr In Indiabulls Pharma

Temasek Acquires Rs 1000 Cr Stake In Manipal Hospitals

Singapore’s Temasek Holding has agreed to acquire a Rs 1,000-crore stake in Manipal Hospitals in a deal that possibly turns the Bengaluru-based private healthcare network into an industry consolidator.

Analytica ANACON India And India Lab Expo 2017

259 exhibitors showcase products

China's Maiden Billion-Dollar Takeover Of An Indian Pharma Giant

The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio.

Top 10 BioSpectrum Articles of 2016

In a year, BioSpectrum covers a wide array of topics from the life sciences sector which comprises among others biotechnology and allied areas, bio-pharma and pharma, healthcare and med technology etc.

Strategic HR for Today's Biotech M&As

The pharmaceutical and bio-technology sectors have been witnessing a strong trend of consolidation through mergers and acquisitions (M&A) over the last few years.

We Are Witnessing a Vibrant and Energetic Business Growth in India

The recent statistics indicate that the Indian pharmaceutical market is currently valued at USD25 billion and is expected to further grow at a CAGR of 12 per cent till 2020. India is the third largest pharmaceutical market in the world by incremental growth and seventh largest by volume, which gives a plethora of opportunities for many life sciences companies. With India’s population expected to reach 1.4 billion in 2022 (as per the 2015 UN Report on World Population), this growing population demands not only large scale production of vaccines but also research for newer vaccines relevant to India and immunotherapy. In order to meet the growing demands of the denizens of the country, Corning Life Sciences, one of the leaders in developing, manufacturing and global supplier of scientific laboratory products for over 100 years, has rolled its sleeves to achieve its goal. Outside of US, India and China are two of the biggest markets for Corning Life Sciences (CLS). In a recent conversation with BioSpectrum, Dr. Richard M. Eglen, Vice President and General Manager, Corning Life Sciences (CLS), and President, Corning International Emerging Market, revealed the expansion plans of CLS and how the company is gearing up to achieve its goal.

We are excited to be a part of this life sciences Industry

We are excited to be a part of this life sciences Industry

Empowered By Innovation

We are setting up Med Tech Accelerator within our existing state of art campus.

Invest In It Backbone And Interoperability Standards In Healthcare

Digital technologies can help both private and public sector’s program leaders to improve service delivery for all and the digital health programmes would have much deeper impact for rural masses

Karnataka To Work On Health Technologies

Policy and Regulatory News